doi: 10.1507/endocrj.EJ21-0802 Gutierrez AD, Gao Z, Hamidi V, et al
Its not about having the best data as you progress your asset through its development cycle, its understanding and planning the strategic moves you need to make to maximise your opportunity, widening your focus and ensuring you have a position to dominate
For labs comparing protocols, a simple matrix often helps: Need lower procedural complexity: Start with a once-daily framework
[1] [2] It is not available through NHS prescribing pathways, and access outside of a registered clinical trial is not supported under standard UK regulatory frameworks
Gedalia built TrufaMED around physician-led protocols, Joint Commission accreditation, and a standard of care usually reserved for hospital systems